GGrantIndex
← Leaderboards

Maria Laura Gennaro

Public Health Research Institute

$14,194,823
Attributed
$26,295,865
Total exposure
14
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.8M · FY200523
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$26,295,865 · 14

By mechanism

R01$20,232,818 · 6
R33$3,042,485 · 1
R61$1,604,701 · 1
R21$1,395,861 · 4
R13$20,000 · 2

Most similar at Public Health Research Institute

Same institution · by research overlap

Others in their field

Top investigators on “Infection

Research focus

InfectionMycobacterium TuberculosisCellsDiagnosticSamplingTuberculosisResponseImmuneBaseComplexMediatingGenesDiagnosisPeripheral BloodProgramsGene ExpressionLatent InfectionBacteriaLeadImmune ResponsePersonsCytokineBiological MarkersCharacteristics

Grant awards (46)

COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)$1,524,793
R33 · FY2023 · HD
COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)$1,517,692
R33 · FY2023 · HD
Cohort and biomarkers for COVID-19 severity, natural history, and reinfection$784,970
R01 · FY2023 · AI
Foam cells as drug targets in tuberculosis$787,112
R01 · FY2022 · HL · contact PI
Cohort and biomarkers for COVID-19 severity, natural history, and reinfection$784,970
R01 · FY2022 · AI
COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)$764,466
R61 · FY2022 · HD
Cohort and biomarkers for COVID-19 severity, natural history, and reinfection$220,634
R01 · FY2022 · AI
COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)$840,235
R61 · FY2021 · HD
Foam cells as drug targets in tuberculosis$787,897
R01 · FY2021 · HL · contact PI
Cohort and biomarkers for COVID-19 severity, natural history, and reinfection$784,970
R01 · FY2021 · AI
Sex hormones and innate immunity in tuberculosis$196,146
R21 · FY2021 · AI · contact PI
Foam cells as drug targets in tuberculosis$787,457
R01 · FY2020 · HL · contact PI
Effects of donor plasma and recipient characteristics on convalescent plasma treatment outcome of COVID-19$753,853
R01 · FY2020 · HL · contact PI
Foam cells as drug targets in tuberculosis$801,457
R01 · FY2019 · HL · contact PI
FISH-Flow platform for host-based tuberculosis diagnostics$972,010
R01 · FY2017 · AI · contact PI
FISH-Flow platform for host-based tuberculosis diagnostics$1,001,681
R01 · FY2016 · AI · contact PI
Rapid Analysis of Single T Cell Immunity Signatures in Tuberculosis$809,946
R01 · FY2016 · AI
Rapid Analysis of Single T Cell Immunity Signatures in Tuberculosis$40,066
R01 · FY2016 · AI
FISH-Flow platform for host-based tuberculosis diagnostics$1,072,330
R01 · FY2015 · AI · contact PI
Rapid Analysis of Single T Cell Immunity Signatures in Tuberculosis$749,849
R01 · FY2015 · AI
FISH-Flow platform for host-based tuberculosis diagnostics$1,123,270
R01 · FY2014 · AI · contact PI
Rapid Analysis of Single T Cell Immunity Signatures in Tuberculosis$749,849
R01 · FY2014 · AI
FISH-Flow platform for host-based tuberculosis diagnostics$1,354,623
R01 · FY2013 · AI · contact PI
Rapid Analysis of Single T Cell Immunity Signatures in Tuberculosis$727,237
R01 · FY2013 · AI
Mapping and modeling host-pathogen interactions in TB latency and reactivation$684,605
R01 · FY2013 · HL · contact PI
Biomarkers for tuberculosis: new questions, new tools$5,000
R13 · FY2013 · AI · contact PI
Mapping and modeling host-pathogen interactions in TB latency and reactivation$716,036
R01 · FY2012 · HL · contact PI
Rapid Analysis of Single T Cell Immunity Signatures in Tuberculosis$379,614
R01 · FY2012 · AI
Rapid Analysis of Single T Cell Immunity Signatures in Tuberculosis$370,018
R01 · FY2012 · AI
Mapping and modeling host-pathogen interactions in TB latency and reactivation$202,768
R01 · FY2012 · HL · contact PI
Sigma factor networks of M. tuberculosis$103,215
R21 · FY2012 · AI · contact PI
Sigma factor networks of M. tuberculosis$93,669
R21 · FY2012 · AI · contact PI
Mapping and modeling host-pathogen interactions in TB latency and reactivation$726,212
R01 · FY2011 · HL · contact PI
Sigma factor networks of M. tuberculosis$229,240
R21 · FY2011 · AI · contact PI
Mapping and modeling host-pathogen interactions in TB latency and reactivation$771,347
R01 · FY2010 · HL · contact PI
Immunodiagnosis of tuberculosis: new questions, new tools$15,000
R13 · FY2008 · AI · contact PI
Proteome screening for tuberculosis outcome markers$184,162
R21 · FY2007 · AI · contact PI
Proteome screening for tuberculosis outcome markers$125,307
R21 · FY2006 · AI · contact PI
Antibody profiles characteristic of tuberculosis state$116,659
R21 · FY2006 · AI · contact PI
Proteome screening for tuberculosis outcome markers$100,263
R21 · FY2006 · AI · contact PI
Antibody profiles characteristic of tuberculosis state$46,826
R21 · FY2006 · AI · contact PI
Antibody profiles characteristic of tuberculosis state$200,374
R21 · FY2005 · AI
IMMUNOLOGICAL DIAGNOSIS OF TUBERCULOSIS$57,916
R01 · FY2003 · AI
IMMUNOLOGICAL DIAGNOSIS OF TUBERCULOSIS$422,145
R01 · FY2002 · AI
IMMUNOLOGICAL DIAGNOSIS OF TUBERCULOSIS$409,922
R01 · FY2001 · AI
IMMUNOLOGICAL DIAGNOSIS OF TUBERCULOSIS$398,054
R01 · FY2000 · AI